Quest Diagnostics
DGX
#931
Rank
โ‚น2.519 T
Marketcap
โ‚น22,826
Share price
1.22%
Change (1 day)
43.40%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น819.41

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น879.86. In 2025 the company made an earnings per share (EPS) of โ‚น851.08 an increase over its 2024 EPS that were of โ‚น746.49.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น819.41-3.72%
2025โ‚น851.0814.01%
2024โ‚น746.492.5%
2023โ‚น728.26-5.83%
2022โ‚น773.36-49.21%
2021โ‚น1,52349.72%
2020โ‚น1,01766.67%
2019โ‚น610.2418%
2018โ‚น517.17-4.26%
2017โ‚น540.2023.19%
2016โ‚น438.49-7.11%
2015โ‚น472.0728.46%
2014โ‚น367.49-31.61%
2013โ‚น537.3260.46%
2012โ‚น334.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,090 23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น68.29-107.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น73.88-108.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น186.91-78.76%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น20.15-102.29%๐Ÿ‡บ๐Ÿ‡ธ USA